The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations.
Saved in:
| Title: | The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations. |
|---|---|
| Authors: | Balasooriya ER; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; The Cancer Program, Broad Institute, Cambridge, Massachusetts., Wu Q; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; The Cancer Program, Broad Institute, Cambridge, Massachusetts., Ellis H; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; The Cancer Program, Broad Institute, Cambridge, Massachusetts., Zhen Y; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; The Cancer Program, Broad Institute, Cambridge, Massachusetts., Norden BL; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Corcoran RB; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Mohan A; Kinnate Biopharma Inc. San Diego, California., Martin E; Kinnate Biopharma Inc. San Diego, California., Franovic A; Kinnate Biopharma Inc. San Diego, California., Tyhonas J; Kinnate Biopharma Inc. San Diego, California., Lardy M; Kinnate Biopharma Inc. San Diego, California., Grandinetti KB; Kinnate Biopharma Inc. San Diego, California., Pelham R; Kinnate Biopharma Inc. San Diego, California., Soroceanu L; Kinnate Biopharma Inc. San Diego, California., Silveira VS; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; The Cancer Program, Broad Institute, Cambridge, Massachusetts., Bardeesy N; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; The Cancer Program, Broad Institute, Cambridge, Massachusetts. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2181-2192. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
